Skeletal response in rats following the implantation of hypercalcemia-producing Leydig cell tumors

Cherk S. Tam, Johan N M Heersche, Arthur Santora, Allen M. Spiegel

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The effect of Rice H-500 Leydig cell tumor tissue on bone in rats was assessed by morphometric analysis and tetracycline labeling of the lower femoral metaphyses. The rats in which tumor was implanted showed hypercalcemia, increased osteoclastic bone resorption, inhibition of bone formation with reduction in the bone apposition rate, and a loss in trabecular volume compared with the control rats. There was no evidence of tumor metastasis to bone. The results are consistent with the hypothesis that the Leydig cell tumor secretes a humoral factor capable of causing systemic bone resorption.

Original languageEnglish (US)
Pages (from-to)50-53
Number of pages4
JournalMetabolism
Volume33
Issue number1
DOIs
StatePublished - 1984
Externally publishedYes

Fingerprint

Leydig Cell Tumor
Hypercalcemia
Bone Resorption
Bone and Bones
Thigh
Tetracycline
Osteogenesis
Neoplasms
Neoplasm Metastasis

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Skeletal response in rats following the implantation of hypercalcemia-producing Leydig cell tumors. / Tam, Cherk S.; Heersche, Johan N M; Santora, Arthur; Spiegel, Allen M.

In: Metabolism, Vol. 33, No. 1, 1984, p. 50-53.

Research output: Contribution to journalArticle

Tam, Cherk S. ; Heersche, Johan N M ; Santora, Arthur ; Spiegel, Allen M. / Skeletal response in rats following the implantation of hypercalcemia-producing Leydig cell tumors. In: Metabolism. 1984 ; Vol. 33, No. 1. pp. 50-53.
@article{e063d7b85f384359be352707286efdd3,
title = "Skeletal response in rats following the implantation of hypercalcemia-producing Leydig cell tumors",
abstract = "The effect of Rice H-500 Leydig cell tumor tissue on bone in rats was assessed by morphometric analysis and tetracycline labeling of the lower femoral metaphyses. The rats in which tumor was implanted showed hypercalcemia, increased osteoclastic bone resorption, inhibition of bone formation with reduction in the bone apposition rate, and a loss in trabecular volume compared with the control rats. There was no evidence of tumor metastasis to bone. The results are consistent with the hypothesis that the Leydig cell tumor secretes a humoral factor capable of causing systemic bone resorption.",
author = "Tam, {Cherk S.} and Heersche, {Johan N M} and Arthur Santora and Spiegel, {Allen M.}",
year = "1984",
doi = "10.1016/0026-0495(84)90161-6",
language = "English (US)",
volume = "33",
pages = "50--53",
journal = "Metabolism: Clinical and Experimental",
issn = "0026-0495",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Skeletal response in rats following the implantation of hypercalcemia-producing Leydig cell tumors

AU - Tam, Cherk S.

AU - Heersche, Johan N M

AU - Santora, Arthur

AU - Spiegel, Allen M.

PY - 1984

Y1 - 1984

N2 - The effect of Rice H-500 Leydig cell tumor tissue on bone in rats was assessed by morphometric analysis and tetracycline labeling of the lower femoral metaphyses. The rats in which tumor was implanted showed hypercalcemia, increased osteoclastic bone resorption, inhibition of bone formation with reduction in the bone apposition rate, and a loss in trabecular volume compared with the control rats. There was no evidence of tumor metastasis to bone. The results are consistent with the hypothesis that the Leydig cell tumor secretes a humoral factor capable of causing systemic bone resorption.

AB - The effect of Rice H-500 Leydig cell tumor tissue on bone in rats was assessed by morphometric analysis and tetracycline labeling of the lower femoral metaphyses. The rats in which tumor was implanted showed hypercalcemia, increased osteoclastic bone resorption, inhibition of bone formation with reduction in the bone apposition rate, and a loss in trabecular volume compared with the control rats. There was no evidence of tumor metastasis to bone. The results are consistent with the hypothesis that the Leydig cell tumor secretes a humoral factor capable of causing systemic bone resorption.

UR - http://www.scopus.com/inward/record.url?scp=0021336055&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021336055&partnerID=8YFLogxK

U2 - 10.1016/0026-0495(84)90161-6

DO - 10.1016/0026-0495(84)90161-6

M3 - Article

C2 - 6690886

AN - SCOPUS:0021336055

VL - 33

SP - 50

EP - 53

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

SN - 0026-0495

IS - 1

ER -